Hampton Creek Press (print and distribution provided by Simon & Schuster) Announces Behind a Closed Door, the Latest Novel by Writer J.D. Barker
April 17, 2024 13:51 ET | Hampton Creek Press
The long-awaited thriller from New York Times bestselling author J.D. Barker is available for preorder now and will be released on May 13, 2024.
Atyr_Logo.png
aTyr Pharma to Participate in April Investor Conferences
April 01, 2024 08:00 ET | aTyr Pharma, Inc.
aTyr Pharma to Participate in April Investor Conferences
Atyr_Logo.png
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
January 29, 2024 08:00 ET | aTyr Pharma, Inc.
aTyr Pharma to present posters on the importance of Neuropilin-2 in immune regulation at the Keystone Symposia on Myeloid Cell Diversity.
canvas (13)
Salt Market to Hit USD 48.6 Billion by 2030 | Fortune Business Insights™
December 11, 2023 00:40 ET | Fortune Business Insights
Pune, India, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The global salt market size was valued at USD 32.6 billion in 2022 and is projected to grow from USD 34.1 billion in 2023 to USD 48.6 billion by 2030,...
Atyr_Logo.png
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
November 13, 2023 08:00 ET | aTyr Pharma, Inc.
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its...
Atyr_Logo.png
aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
November 09, 2023 16:00 ET | aTyr Pharma, Inc.
Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected to complete enrollment early in the second quarter of 2024. Phase 2 EFZO-CONNECT™ study of efzofitimod in SSc-ILD initiated...
Atyr_Logo.png
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
September 11, 2023 08:00 ET | aTyr Pharma, Inc.
Post-hoc analysis from Phase 1b/2a study in pulmonary sarcoidosis presented at the European Respiratory Society (ERS) International Congress 2023. 7.7% of patients in the 3.0 and 5.0 mg/kg...
RationalStat Logo 1.png
Philippines Industrial Salt Market Set to Reach US$ 38.8 million by 2030, registering a CAGR of over 3.7% | Market Report by RationalStat
September 01, 2023 01:59 ET | Rationalstat LLC
Wilmington, Delaware, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Philippines Industrial Salt Market is valued at US$ 30 million in 2022 and is expected to grow at a significant CAGR of over 3.7% over the...
FBI LOGO TM.png
Salt Market to Reach USD 48.6 Billion by 2030 | With a CAGR of 5.2%
July 12, 2023 08:00 ET | Fortune Business Insights
Pune, India, July 12, 2023 (GLOBE NEWSWIRE) -- The global salt market size was valued at USD 32.6 billion in 2022 and is projected to grow from USD 34.1 billion in 2023 to USD 48.6 billion by 2030,...
Klang-Lgog-ryb-rgb50.png
“The Life Cycle” Podcast from Klang Games Clarifies the Most Important Questions About the Future of Mankind
April 06, 2023 09:30 ET | Klang Games
BERLIN, April 06, 2023 (GLOBE NEWSWIRE) -- Klang Games, the makers behind the sandbox simulation MMO game SEED, are not only concerned with the future of mankind and the colonization of exoplanets...